It prevents GPCR desensitization by binding to the active site of GRK2 (4), and has been extensively reported to have benefits in osteoarthritis, cardiac hypertrophy, myocardial infarction, and heart failure (4–9). This evidence concerns the gene GRK2 and heart failure.